CAS
NVO

Cue Advisory Services’s Novo Nordisk NVO Stock Holding History

Cue Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,280
Closed -$220K – 163
2017
Q2 		$220K Buy
+10,280
New +$207K 0.16% 147

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Cue Advisory Services's NVO Position: Q3 2017 in Review

Cue Advisory Services sold out of Novo Nordisk (NVO) in Q3 2017, closing a stake of 10,280 shares — an estimated $220K sold.

Cue Advisory Services first reported a position in NVO in Q2 2017 and held it in 1 quarter. The position peaked at $220K in Q2 2017. 491 funds tracked by Wall St. Rank hold NVO as of Q3 2017.

  • Cue Advisory Services reported no remaining Novo Nordisk position as of Q3 2017 after selling out during the quarter.
  • Cue Advisory Services sold 10,280 Novo Nordisk shares in Q3 2017, an estimated $220K.
  • Cue Advisory Services first reported a position in Novo Nordisk in Q2 2017 and held it in 1 quarter.
  • Cue Advisory Services's Novo Nordisk position peaked at $220K in Q2 2017.
  • 491 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2017.

Based on Cue Advisory Services's 13F filing for Q3 2017, filed 24 Oct 2017.